Consumer
If Ozempic Leads People to Eat Less, Maker of Cheez-It Will Be Ready
- Kellanova prepared for mitigation if needed, Cahillane says
- Former Kellogg Co. just completed separation from cereal arm
Diabetes drug Ozempic and other appetite-suppressing medications are set to help overweight Americans cut down on their calorie intake. US food companies are unlikely to sit idly by.
“We’re by no means complacent,” Kellanova Chief Executive Officer Steve Cahillane said in an interview Monday.
Have a confidential tip for our reporters? Get in Touch
Before it’s here, it’s on the Bloomberg Terminal
LEARN MORE
Up Next
If Ozempic Leads People to Eat Less, Maker of Cheez-It Will Be Ready